Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation
Clinical trial NCT00087009 · TERMINATED
Trial details
- NCT number
- NCT00087009
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.